Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.

about

Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.The potential contribution of ranolazine to Torsade de Pointe.

P2860

Q35873307-D54DCDB1-4A4A-45E2-9301-A390AE0A4DE8 Q37360981-737D0029-43B1-4797-AB42-4DE345A3FDAD

P2860

Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.

Item

http://www.wikidata.org/entity/Q38074900

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Ranolazine: a review of its us ...... hronic stable angina pectoris.

@en

type

Item

label

Ranolazine: a review of its us ...... hronic stable angina pectoris.

@en

prefLabel

Ranolazine: a review of its us ...... hronic stable angina pectoris.

@en

P1476

Ranolazine: a review of its us ...... hronic stable angina pectoris.

@en

P2860

Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action

Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine

Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome.

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

P2888

s40265-012-0005-z

P304

55-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-012-0005-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gillian M Keating

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009325068

http://www.w3.org/2001/XMLSchema#string

P698

23329466

http://www.w3.org/2001/XMLSchema#string

Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.

about

P2860

P2860

Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698